The University of Iowa Center for Biocatalysis and Bioprocessing (CBB) collaborates yearly with more than 60 industrial companies and institutions to produce vaccines, antibiotics, anti-cancer drugs, polymers, BL2-LS pathogens, biochemicals, ensymes, pharmaceutical intermediates, and derivatives of bioactive compounds. The CBB is composed of a university-wide consortium using state-of-the-art facilities with the aim of providing world-class education and training, research and scholarship, as well as wide-ranging technology transfer activities in the real of biotechnology.
The W.M. Keck Dynamic Image Analysis Facility provides the most advanced two-dimensional and three-dimensional dynamic image analysis systems now available in the world for reconstructing and motion analyzing the dynamics of organs, tissues, cells, and subcellular compartments. This facility's two missions are to develop both hardware and software for advanced 2D and 3D reconstruction and motion analysis systems, and to provide scientists access to these emerging technologies. The facility employs three of the most advanced systems (2-DIAS, 3-DIAS, and the dynamic echocardiogram analysis system DEAS) to serve biomedical research scientists interested in motile forms.
The Iowa Comprehensive Lung Imaging Center employs quantitative imaging techniques to better understand the normal lung and the changes leading to and defining pathologic states. Based on a truly multidisciplinary foundation, this facility provides the means for interacting with and influencing industrial partners in regards to future directions of the development of imaging technologies, while advancing the fields of both lung imaging and our understanding of the lung. One of the goals of the originators of this facility is to establish a normal atlas of the human lung based on newly developed methods of x-ray CT scanning.
The Iowa Institute for Biomedical Imaging fosters efficient multidisciplinary and cross-college research in biomedical imaging using state-of-the-art equipment, while supporting training and education in this area. The Institute also manages the acquisition of imaging devices and oversees their maintenance, and aids in the development of new devices. Data processing and analysis, and file archiving and retrieval are among our missions, which are carried out using a true bi-directional, translational approach, with an eye toward patient applicability.
The Tissue Culture/Hybridoma Core is part of the Holden Comprehensive Cancer Center at the University of Iowa and provides hybridoma services, molecular biology kits and supplies, cell culture media and supplies, and protein chemistry supplies. The Tissue Culture/Hybridoma Core is also linked to the Department of Biology's Developmental Studies Hybridoma Bank (http://dshb.biology.uiowa.edu/), which provides antibodies and cells for a range of applications.
The Virtual Reality Laboratory (VR) at the University of Iowa has developed novel technologies for visualization of physics-based simulations using photo realistic graphics that are based on PC workstations. The VR Laboratory was established in 1998 with major funding from Allsteel, Inc., and has deployed VR technologies to Fortune 500 companies such as Maytag, Deere, and Hon Industries. The laboratory uses both active and passive stereoscopic visualization and is equipped with large-screen and multiwall systems that use LVD, CRT, and DLP projectors as well as state-of-the-art display technologies.
